Association of metoprolol and retroperitoneal fibrosis.
Ahmad
S
S
Cardio-Diagnostic Clinique, Fairmont, WV 26554, USA.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000328:Adult; D000959:Antihypertensive Agents / Q000009:adverse effects*; D003251:Constriction, Pathologic / Q000139:chemically induced; D004487:Edema / Q000139:chemically induced; D005260:Female; D006801:Humans; D006869:Hydronephrosis / Q000139:chemically induced; D008790:Metoprolol / Q000009:adverse effects*; D012185:Retroperitoneal Fibrosis / Q000139:chemically induced*; D014515:Ureteral Diseases / Q000139:chemically induced; D014581:Urticaria / Q000139:chemically induced
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D008790:Metoprolol